Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis
2010; Oxford University Press; Volume: 102; Issue: 9 Linguagem: Inglês
10.1093/jnci/djq101
ISSN1460-2105
AutoresKarla Kerlikowske, Annette M. Molinaro, Marie-Pier Gauthier, Hal K. Berman, F. Waldman, James L. Bennington, Henry Sánchez, Cristina Roldán Jiménez, Keith Stewart, Karen Chew, Britt‐Marie Ljung, Thea D. Tlsty,
Tópico(s)HER2/EGFR in Cancer Research
ResumoBackgroundStudies have failed to identify characteristics of women who have been diagnosed with ductal carcinoma in situ (DCIS) and have a high or low risk of subsequent invasive cancer.
Referência(s)